Radnor Capital Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.94M Sell
34,100
-40
-0.1% -$3.59K 0.43% 53
2025
Q4
$2.98M Buy
34,140
+1,004
+3% +$76.2K 0.44% 54
2025
Q3
$1.9M Buy
33,136
+320
+1% +$18.4K 0.29% 98
2025
Q2
$1.94M Buy
32,816
+2,555
+8% +$165K 0.31% 88
2025
Q1
$2.21M Buy
30,261
+1,200
+4% +$99.2K 0.37% 68
2024
Q4
$2.4M Sell
29,061
-910
-3% -$71.8K 0.4% 65
2024
Q3
$2.14M Buy
+29,971
New +$2.12M 0.32% 82
2024
Q2
Sell
-29,101
Closed -$1.56M 207
2024
Q1
$1.56M Buy
29,101
+215
+0.7% +$11.6K 0.27% 99
2023
Q4
$1.54M Buy
28,886
+3,295
+13% +$161K 0.29% 92
2023
Q3
$1.27M Buy
+25,591
New +$1.43M 0.25% 102
2023
Q2
Sell
-8,981
Closed -$509K 175
2023
Q1
$509K Buy
+8,981
New +$576K 0.13% 146

Other funds holding GMED